Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity
Author:
Huisi Liu,Weiwei Wu,Gangyu Sun,Tiongsun Chia,Lei Cao,Xiaodan Liu,Jian Guan,Fenggen Fu,Ying Yao,Zhihai Wu,Shuaixiang Zhou,Jie Wang,Jia Lu,Zhihui Kuang,Min Wu,Luan He,Zhiyuan Shao,Dongdong Wu,Bingliang Chen,Wenqing Xu,Zhizhi Wang,Kaijie He
Publication:
Cell Reports Medicine